These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 1963290)
1. Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II. Moreau NJ; Robaux H; Baron L; Tabary X Antimicrob Agents Chemother; 1990 Oct; 34(10):1955-60. PubMed ID: 1963290 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus. Hoshino K; Sato K; Une T; Osada Y Antimicrob Agents Chemother; 1989 Oct; 33(10):1816-8. PubMed ID: 2556080 [TBL] [Abstract][Full Text] [Related]
3. Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I. Tabary X; Moreau N; Dureuil C; Le Goffic F Antimicrob Agents Chemother; 1987 Dec; 31(12):1925-8. PubMed ID: 2830840 [TBL] [Abstract][Full Text] [Related]
4. DNA topoisomerases from Streptomyces noursei: influence of coumarins and quinolones on the enzymic activity. Störl K; Störl J; Roth M; Zimmer C Biochim Biophys Acta; 1994 Mar; 1199(2):143-8. PubMed ID: 8123663 [TBL] [Abstract][Full Text] [Related]
5. Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases. Hoshino K; Sato K; Akahane K; Yoshida A; Hayakawa I; Sato M; Une T; Osada Y Antimicrob Agents Chemother; 1991 Feb; 35(2):309-12. PubMed ID: 1850968 [TBL] [Abstract][Full Text] [Related]
6. Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli. Neumann S; Quiñones A J Basic Microbiol; 1997; 37(1):53-69. PubMed ID: 9090126 [TBL] [Abstract][Full Text] [Related]
7. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases. Blanche F; Cameron B; Bernard FX; Maton L; Manse B; Ferrero L; Ratet N; Lecoq C; Goniot A; Bisch D; Crouzet J Antimicrob Agents Chemother; 1996 Dec; 40(12):2714-20. PubMed ID: 9124828 [TBL] [Abstract][Full Text] [Related]
8. Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa. Kitamura A; Hoshino K; Kimura Y; Hayakawa I; Sato K Antimicrob Agents Chemother; 1995 Jul; 39(7):1467-71. PubMed ID: 7492087 [TBL] [Abstract][Full Text] [Related]
9. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition. Hoshino K; Kitamura A; Morrissey I; Sato K; Kato J; Ikeda H Antimicrob Agents Chemother; 1994 Nov; 38(11):2623-7. PubMed ID: 7872758 [TBL] [Abstract][Full Text] [Related]
10. Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts. Hussy P; Maass G; Tümmler B; Grosse F; Schomburg U Antimicrob Agents Chemother; 1986 Jun; 29(6):1073-8. PubMed ID: 3015015 [TBL] [Abstract][Full Text] [Related]
11. The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analogues. Lawrence LE; Wu P; Fan L; Gouveia KE; Card A; Casperson M; Denbleyker K; Barrett JF J Antimicrob Chemother; 2001 Aug; 48(2):195-201. PubMed ID: 11481288 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of quinolones against Escherichia coli DNA gyrase. Yoshida H; Nakamura M; Bogaki M; Ito H; Kojima T; Hattori H; Nakamura S Antimicrob Agents Chemother; 1993 Apr; 37(4):839-45. PubMed ID: 8388200 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis. Onodera Y; Tanaka M; Sato K J Antimicrob Chemother; 2001 Apr; 47(4):447-50. PubMed ID: 11266418 [TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance. Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005 [TBL] [Abstract][Full Text] [Related]
15. DNA gyrase, topoisomerase IV, and the 4-quinolones. Drlica K; Zhao X Microbiol Mol Biol Rev; 1997 Sep; 61(3):377-92. PubMed ID: 9293187 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus. Tanaka M; Onodera Y; Uchida Y; Sato K; Hayakawa I Antimicrob Agents Chemother; 1997 Nov; 41(11):2362-6. PubMed ID: 9371334 [TBL] [Abstract][Full Text] [Related]
17. In vitro cleavable-complex assay to monitor antimicrobial potency of quinolones. Walton L; Elwell LP Antimicrob Agents Chemother; 1988 Jul; 32(7):1086-9. PubMed ID: 2847641 [TBL] [Abstract][Full Text] [Related]
18. Characterization of Campylobacter jejuni DNA gyrase as the target of quinolones. Changkwanyeun R; Usui M; Kongsoi S; Yokoyama K; Kim H; Suthienkul O; Changkaew K; Nakajima C; Tamura Y; Suzuki Y J Infect Chemother; 2015 Aug; 21(8):604-9. PubMed ID: 26096494 [TBL] [Abstract][Full Text] [Related]
19. Antibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and its optical isomers against type II topoisomerases. Akasaka T; Kurosaka S; Uchida Y; Tanaka M; Sato K; Hayakawa I Antimicrob Agents Chemother; 1998 May; 42(5):1284-7. PubMed ID: 9593169 [TBL] [Abstract][Full Text] [Related]
20. Impact of mutations in DNA gyrase genes on quinolone resistance in Campylobacter jejuni. Changkwanyeun R; Yamaguchi T; Kongsoi S; Changkaew K; Yokoyama K; Kim H; Suthienkul O; Usui M; Tamura Y; Nakajima C; Suzuki Y Drug Test Anal; 2016 Oct; 8(10):1071-1076. PubMed ID: 26857529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]